Showing results (111-120 of 166) with videos related to
Sort By:
Pageof 17
The Tohoku Journal of Experimental Medicine|August 9, 2023
Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes with Donor-Specific Anti-HLA Antibodies against HLA-DPYusuke Uchibori, Koichi Onodera, Yasushi Onishi, et al.Cancer Science|September 13, 2016
Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphomaDai Maruyama, Hirokazu Nagai, Noriko Fukuhara, et al.Cancer Science|March 25, 2022
Two-year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemiaNaohiro Sekiguchi, Shinya Rai, Wataru Munakata, et al.International Journal of Hematology|October 23, 2020
Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphomaKoji Izutsu, Kazuhito Yamamoto, Koji Kato, et al.Cancer Science|July 9, 2020
A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström's macroglobulinemiaNaohiro Sekiguchi, Shinya Rai, Wataru Munakata, et al.Journal of Clinical and Experimental Hematopathology : JCEH|July 3, 2024
Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in JapanMotoko Yamaguchi, Noriko Fukuhara, Jun Takizawa, et al.Clinical Lymphoma, Myeloma & Leukemia|December 14, 2025
Dismal Outcome of EBV-Positive Nodal T/NK-Cell Lymphoma: A Multicenter Retrospective StudySatoshi Ichikawa, Noriko Fukuhara, Yuna Katsuoka, et al.Human Pathology|November 19, 2018
Immunohistochemical pattern of c-MYC protein judged as "+/(weak)+/-" by a new notation correlates with MYC gene nontranslocation in large B-cell lymphomaFumiyoshi Fujishima, Hiroki Katsushima, Noriko Fukuhara, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 30, 2024
Plasma Venetoclax Concentrations in Patients with Acute Myeloid Leukemia Treated with CYP3A4 InhibitorsAyaka Otsuki, Masaki Kumondai, Daisuke Kobayashi, et al.International Journal of Clinical Oncology|December 29, 2023
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphomaHideki Goto, Satoshi Ito, Masahiro Kizaki, et al.Pageof 17